Observational Usage Study of Statins in Primary Care in France
Completed
- Conditions
- Healthy
- Registration Number
- NCT00680082
- Lead Sponsor
- AstraZeneca
- Brief Summary
To describe the way statins are used in France in primary care, that is to determine patients profile (particularly CV risk factors), to determine the way statins are initiated by general practitioners, to evaluate aftercare and to assess patients treated by rosuvastatin
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2100
Inclusion Criteria
- Patients to whom a statin was initiated or switched between 3 and 6 months before consultation
Read More
Exclusion Criteria
Not provided
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Research Site
🇨🇳Wenzhou, Zhejiang, China